-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price Target

Benzinga·07/13/2026 19:00:08
语音播报
Wells Fargo analyst Derek Archila upgrades Q32 Bio (NASDAQ:QTTB) from Equal-Weight to Overweight and announces $66 price target.